Development of novel spectroscopic and machine learning methods for the measurement of periodic changes in COVID-19 antibody level

In this research, blood samples of 47 patients infected by COVID were analyzed. The samples were taken on the 1st, 3rd and 6th month after the detection of COVID infection. Total antibody levels were measured against the SARS-CoV-2 N antigen and surrogate virus neutralization by serological methods. To differentiate COVID patients with different antibody levels, Fourier Transform InfraRed (FTIR) and Raman spectroscopy methods were used. The spectroscopy data were analyzed by multivariate analysis, machine learning and neural network methods. It was shown, that analysis of serum using the above-mentioned spectroscopy methods allows to differentiate antibody levels between 1 and 6 months via spectral biomarkers of amides II and I. Moreover, multivariate analysis showed, that using Raman spectroscopy in the range between 1317 cm(-1 )and 1432 cm(-1) , 2840 cm(-1) and 2956 cm(-1) it is possible to distinguish patients after 1, 3, and 6 months from COVID with a sensitivity close to 100%.

Automated summary

This research analyzed blood samples from 47 COVID-infected patients using FTIR and Raman spectroscopy methods to differentiate patients with different antibody levels. The results showed that these spectroscopy methods could differentiate antibody levels and distinguish COVID patients from previously infected patients after 1, 3, and 6 months.